Since cancer stem cells (CSCs) were first identified in leukemia in 1994, they have been
considered promising therapeutic targets for cancer therapy. These cells have self-renewal …

Recently, we presented evidence that high mitochondrial ATP production is a new
therapeutic target for cancer treatment. Using ATP as a biomarker, we isolated the …

Prostate cancer (PCa) is the most diagnosed malignancy in the men worldwide. Cancer
stem cells (CSCs) are the sub-population of cells present in the tumor which possess unique …

Compelling evidence has demonstrated that tumor bulk comprises distinctive subset of cells
generally referred as cancer stem cells (CSCs) that have been proposed as a strong …

Background: Cancer is second leading disease after cardiovascular disease. Presently,
Chemotherapy, Radiotherapy and use of chemicals are some treatments available these …

One of the most significant therapeutic challenges in the treatment of ovarian cancer is the
development of recurrent platinum-resistant disease. Cancer stem cells (CSCs) are …

Cell surface markers are most widely used in the study of cancer stem cells (CSCs).
However, cell surface markers that are safely and stably expressed in CSCs have yet to be …

Breast cancer has been recorded as a frequent malignant cancer. The side effects of current
chemotherapy drugs are still a severe problem. Hence, naturally occurring phytochemicals …

We previously reported that enriched ubiquitinated proteins (UPs) from tumor cells have the
potential to be used as immunotherapy vaccine against cancer. Here we enriched UPs from …

Simple Summary Breast cancer stem cells (BCSCs) are a small population of cells in breast
cancer tumors, playing a putative role in the cancer's progression. BCSC biomarkers are …